EP2393507 - TRIMERIC HIV FUSION INHIBITORS FOR TREATING OR PREVENTING HIV INFECTION [Right-click to bookmark this link] | |||
Former [2011/50] | TRIMERICH HIV FUSION INHIBITORS FOR TREATING OR PREVENTING HIV INFECTION | ||
[2012/07] | Status | The application is deemed to be withdrawn Status updated on 29.05.2015 Database last updated on 31.05.2024 | Most recent event Tooltip | 29.05.2015 | Application deemed to be withdrawn | published on 01.07.2015 [2015/27] | Applicant(s) | For all designated states New York Blood Center, Inc. 310 East 67 Street New York, NY 10065 / US | [2011/50] | Inventor(s) | 01 /
JIANG, Shibo 65-38 Utopia Parkway Fresh Meadows, NY 11365 / US | 02 /
QI, Zhi 98-25 Harding H Expy Apt. 10N Corona, NY 11368 / US | 03 /
CHEN, Xi 87-01 51st Avenue Elmhurst, NY 11373 / US | 04 /
PAN, Chungen Hanjingxuan Building A Apt. 1005 Hanjing Street Wushan Road Tianhe District Guangzhou Guangdong Province 510630 / CN | [2012/02] |
Former [2011/50] | 01 /
JIANGS, Shibo 65-38 Utopia Parkway Fresh Meadows, NY 11365 / US | ||
02 /
QI, Zhi 98-25 Harding H Expy Apt. 10N Corona, NY 11368 / US | |||
03 /
CHEN, Xi 87-01 51st Avenue Elmhurst, NY 11373 / US | |||
04 /
PAN, Chungen Hanjingxuan Building A Apt. 1005 Hanjing Street Wushan Road Tianhe District Guangzhou Guangdong Province 510630 / CN | Representative(s) | Radkov, Stoyan Atanassov Urquhart-Dykes & Lord LLP Euston House 24 Eversholt Street London NW1 1AD / GB | [N/P] |
Former [2013/44] | Radkov, Stoyan Atanassov Urquhart-Dykes & Lord LLP 33 Glasshouse Street London W1B 5DG / GB | ||
Former [2011/50] | Thomas, Simon Urquhart-Dykes & Lord LLP 3rd Floor 33 Glasshouse Street London W1B 5DG / GB | Application number, filing date | 10703782.2 | 08.02.2010 | WO2010US23522 | Priority number, date | US20090151110P | 09.02.2009 Original published format: US 151110 P | [2011/50] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2010091373 | Date: | 12.08.2010 | Language: | EN | [2010/32] | Type: | A2 Application without search report | No.: | EP2393507 | Date: | 14.12.2011 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.08.2010 takes the place of the publication of the European patent application. | [2011/50] | Search report(s) | International search report - published on: | EP | 30.09.2010 | Classification | IPC: | A61K38/17, A61P31/18 | [2011/50] | CPC: |
A61K38/162 (EP,US);
A61P31/18 (EP);
C07K14/005 (EP,US);
C12N7/00 (US);
A61K38/00 (EP,US);
C07K2319/735 (EP,US);
C12N2740/16022 (US);
C12N2740/16033 (US);
C12N2740/16111 (US);
C12N2740/16122 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2011/50] | Title | German: | TRIMERE HIV-FUSIONSHEMMER ZUR BEHANDLUNG ODER VORBEUGUNG DER HIV-INFEKTION | [2011/50] | English: | TRIMERIC HIV FUSION INHIBITORS FOR TREATING OR PREVENTING HIV INFECTION | [2012/07] | French: | INHIBITEURS DE FUSION DU VIH POUR LE TRAITEMENT OU LA PRÉVENTION DE L'INFECTION PAR LE VIH | [2011/50] |
Former [2011/50] | TRIMERICH HIV FUSION INHIBITORS FOR TREATING OR PREVENTING HIV INFECTION | Entry into regional phase | 26.07.2011 | National basic fee paid | 26.07.2011 | Designation fee(s) paid | 26.07.2011 | Examination fee paid | Examination procedure | 26.07.2011 | Amendment by applicant (claims and/or description) | 26.07.2011 | Examination requested [2011/50] | 10.07.2014 | Despatch of a communication from the examining division (Time limit: M06) | 21.01.2015 | Application deemed to be withdrawn, date of legal effect [2015/27] | 17.02.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2015/27] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 10.07.2014 | Fees paid | Renewal fee | 24.02.2012 | Renewal fee patent year 03 | 27.02.2013 | Renewal fee patent year 04 | 27.02.2014 | Renewal fee patent year 05 | 26.02.2015 | Renewal fee patent year 06 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XY]US2004044183 (ECKERT DEBRA M [US], et al) [X] 1,2,8-10 * abstract * [Y] 3-7; | [XY]US2005106177 (SODROSKI JOSEPH G [US], et al) [X] 1-3,8-10 * abstract * * paragraph [0018] - paragraph [0019] * [Y] 3-7; | [X]WO2006038131 (EUROPEAN MOLECULAR BIOLOGY LAB EMBL [DE], et al) [X] 1,2,8-10 * abstract *; | [E]WO2010045613 (NEW YORK BLOOD CT INC [US], et al) [E] 1-4,8-10* sequence 24 *; | [A] - LOUIS JOHN M ET AL, "Covalent trimers of the internal N-terminal trimeric coiled-coil of gp41 and antibodies directed against them are potent inhibitors of HIV envelope-mediated cell fusion", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, INC, US LNKD- DOI:10.1074/JBC.M301627200, vol. 278, no. 22, ISSN 0021-9258, (20030530), pages 20278 - 20285, (20030324), XP002481442 [A] 1-10 * the whole document * DOI: http://dx.doi.org/10.1074/jbc.M301627200 | [A] - LIU SHUWEN ET AL, "HIV entry inhibitors targeting gp41: From polypeptides to small-molecule compounds", CURRENT PHARMACEUTICAL DESIGN, BENTHAM SCIENCE PUBLISHERS, NL LNKD- DOI:10.2174/138161207779313722, (20070101), vol. 13, no. 2, ISSN 1381-6128, pages 143 - 162, XP002499294 [A] 1-10 * the whole document * DOI: http://dx.doi.org/10.2174/138161207779313722 | by applicant | - HENIKOFF; HENIKOFF, PROC. NATL. ACAD SCI. USA, (1992), vol. 89, page 10915 | - NEEDLEMAN; WUNSCH, J. MOL. BIO., (1970), vol. 48, page 443 | - "The use of interspecies scaling in toxicokinetics", MARDENTI, J.; CHAPPELL, W. ET AL., Toxicokinetics and New Drug Development, PERGAMON PRESS, (1989), pages 42 - 96 |